MedCity News September 9, 2021
Elise Reuter

The funding round boosted Flo’s valuation to $800 million. It plans to put the funds toward new technical capabilities and new hires.

Period-tracking app Flo is now valued at $800 million, after closing a recent funding round. The startup recently raised a $50 million series B round, led by VNV Global and Target Global.

The London-based company, which was founded in 2016, claims its period-tracking app has drummed up 200 million users. It also has features for tracking a pregnancy, and makes predictions related to users’ cycles.

But the company has also faced some challenges related to its privacy practices. Earlier this year, Flo settled a lawsuit from the Federal Trade Commission after it allegedly shared information about users who...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, Investments, Technology, Trends
Emirates improves in-flight digital medical care
Ensuring HIPAA Compliance in Telehealth Sessions
Five benefits of a health tech accelerator program
How leveraging cardiac data via RPM can help overcome many clinical challenges
Building A Resilient Digital Infrastructure For Global Enterprises: A Holistic Approach To Transformation

Share This Article